<sup>68</sup>Ga-PSMA-HBED-CC Uptake in Cervical, Celiac, and Sacral Ganglia as an Important Pitfall in Prostate Cancer PET Imaging.

Rischpler, Christoph; Beck, Teresa I; Okamoto, Shozo; Schlitter, Anna M; Knorr, Karina; Schwaiger, Markus; Gschwend, Jürgen; Maurer, Tobias et al. · J Nucl Med · 2018

Where this comes from

Abstract

The study aims to investigate the presence of physiologic prostate-specific membrane antigen (<sup>68</sup>Ga-PSMA)-ligand uptake on PET in cervical, celiac, and sacral ganglia of the sympathetic trunk as a pitfall for lymph node metastases in prostate cancer imaging. <b>Methods:</b> Four hundred seven patients who underwent Glu-NH-CO-NH-Lys radiolabeled with <sup>68</sup>Ga-gallium <i>N,N</i>-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-<i>N,N</i>-diacetic acid (<sup>68</sup>Ga-PSMA-HBED-CC) PET (combined with a diagnostic CT) were retrospectively analyzed. The number of <sup>68</sup>Ga-PSMA PET-positive cervical, celiac, and sacral ganglia was determined, and the configuration and SUV<sub>max</sub> of each ganglion were measured. In addition, the configuration and SUV<sub>max</sub> of adjacent lymph node metastases in the respective region (cervical, celiac, or sacral) were determined. <b>Results:</b><sup>68</sup>Ga-PSMA-ligand uptake above background was detected in 401 (98.5%) patients in any peripheral ganglia, in 369 (92%) patients in cervical ganglia, in 363 (89%) patients in celiac ganglia, and in 183 (46%) patients in sacral ganglia. The <sup>68</sup>Ga-PSMA-ligand uptake was highest in celiac (mean SUV<sub>max</sub>, 2.9 ± 0.8 vs. cervical mean SUV<sub>max</sub>, 2.4 ± 0.6) and sacral (mean SUV<sub>max</sub> 1.7 ± 0.5; both <i>P</i> < 0.0001) ganglia. Intraindividually there was a statistically significant but weak to moderate correlation between the <sup>68</sup>Ga-PSMA-ligand uptake in cervical versus celiac ganglia (<i>R</i> = 0.34, <i>P</i> < 0.0001), cervical versus sacral (<i>R</i> = 0.52, <i>P</i> < 0.0001), and celiac versus sacral (<i>R</i> = 0.16, <i>P</i> < 0.05). The <sup>68</sup>Ga-PSMA-ligand uptake was significantly more intense in adjacent lymph node metastases than the respective ganglia (cervical: 18.0 ± 16.2 vs. 2.4 ± 0.6, <i>P</i> < 0.0001; celiac: 13.5 ± 12.3 vs. 2.9 ± 0.8, <i>P</i> < 0.0001; sacral: 13.4 ± 11.6 vs. 1.7 ± 0.5, <i>P</i> < 0.0001). Furthermore, ganglia predominantly exhibit a band-shaped configuration (71.2%), followed by a teardrop (26.8%) and only rarely a nodular configuration (2.0%). Conversely, lymph node metastases are only rarely band-shaped (1.1%), but more often show teardrop (40.3%) or nodular appearance (58.6%) (<i>P</i> < 0.00001). <b>Conclusion:</b><sup>68</sup>Ga-PSMA-ligand uptake in ganglia along the sympathetic trunk as assessed by <sup>68</sup>Ga-PSMA-HBED-CC PET represents an important pitfall in prostate cancer PET imaging. The <sup>68</sup>Ga-PSMA-ligand uptake is higher in celiac ganglia than cervical or sacral ganglia, and the level of <sup>68</sup>Ga-PSMA-ligand uptake seems to be patient-related. For the differentiation between lymph node metastases and sympathetic ganglia, both intensity of <sup>68</sup>Ga-PSMA-ligand uptake and exact localization and configuration of the respective lesion should be examined carefully.

Medical subject headings